Asserter profile

TRUIST BANK

operating company5 patents now5 ever0 cases filed during tenure3 connections

Also seen as: Truist Bank

PTAB exposure

2of this entity’s patents have been challenged at PTAB (2 total proceedings). 2 had claims invalidated.

Final written decisions are public record. The invalidation grounds usually carry over as § 102 / § 103 ammunition in district court — see IPR estoppel.

Two-hop network

Edges marked ⚖️ overlap with at least one infringement suit filed during the receiving entity’s tenure with the patent. Bold-bordered = this entity. Red = NPE; orange = shell LLC; green = defensive aggregator; blue = operating company.

flowchart LR
    Ntruist_bank["TRUIST BANK"]
    Nlifenet_health_skin_and_wound_allograft_institute["LIFENET HEALTH, SKIN AND WOUND ALLOGRAF…"]
    Nlifenet_health_and_skin_and_wound_allograft_institute["LifeNet Health and Skin and Wound Allog…"]
    Nbraemar_manufacturing["BRAEMAR MANUFACTURING, LLC"]
    Nsuntrust_bank["SunTrust Bank"]
    Ncardionet["CARDIONET, INC."]
    Ngeneral_electric_capital_as_agent["General Electric Capital Corporation, a…"]
    Nhealthcare_financial_solutions["HEALTHCARE FINANCIAL SOLUTIONS, LLC"]
    Nsuntrust_bank_as_administrative_agent["SUNTRUST BANK, AS ADMINISTRATIVE AGENT"]
    Nlifenet_health_skin_and_wound_allograft_institute -->|"2021 · Security Interest · 11318227"| Ntruist_bank
    Nlifenet_health_skin_and_wound_allograft_institute -->|"2021 · Security Interest · 10137223"| Ntruist_bank
    Nlifenet_health_and_skin_and_wound_allograft_institute -->|"2021 · Security Agreement · 6189537"| Ntruist_bank
    Nlifenet_health_skin_and_wound_allograft_institute -->|"2021 · Security Interest · 5977034"| Ntruist_bank
    Nlifenet_health_skin_and_wound_allograft_institute -->|"2021 · Security Interest · 5556379"| Ntruist_bank
    Ntruist_bank -->|"2021 · Release · 6957107"| Nbraemar_manufacturing
    Nlifenet_health_skin_and_wound_allograft_institute -->|"2019 · Security Interest · 11318227"| Nsuntrust_bank
    Nlifenet_health_skin_and_wound_allograft_institute -->|"2015 · Security Agreement · 10137223"| Nsuntrust_bank
    Nlifenet_health_skin_and_wound_allograft_institute -->|"2019 · Security Interest · 10137223"| Nsuntrust_bank
    Nsuntrust_bank -->|"2019 · Release By Secured Party · 10137223"| Nlifenet_health_skin_and_wound_allograft_institute
    Nlifenet_health_skin_and_wound_allograft_institute -->|"2019 · Security Interest · 5977034"| Nsuntrust_bank
    Nlifenet_health_skin_and_wound_allograft_institute -->|"2019 · Security Interest · 5556379"| Nsuntrust_bank
    Nlifenet_health_and_skin_and_wound_allograft_institute -->|"2015 · Security Agreement · 6189537"| Nsuntrust_bank
    Nlifenet_health_and_skin_and_wound_allograft_institute -->|"2019 · Security Agreement · 6189537"| Nsuntrust_bank
    Nsuntrust_bank -->|"2019 · Release · 6189537"| Nlifenet_health_and_skin_and_wound_allograft_institute
    Ncardionet -->|"2012 · Assignment · 6957107"| Nbraemar_manufacturing
    Nbraemar_manufacturing -->|"2014 · Security Interest · 6957107"| Ngeneral_electric_capital_as_agent
    Nhealthcare_financial_solutions -->|"2017 · Release · 6957107"| Nbraemar_manufacturing
    Nbraemar_manufacturing -->|"2017 · Security Interest · 6957107"| Nsuntrust_bank_as_administrative_agent
    classDef focal fill:#fef3c7,stroke:#92400e,stroke-width:3px,color:#1c1917
    classDef npe fill:#fee2e2,stroke:#be123c,stroke-width:2px,color:#1c1917
    classDef shell fill:#fed7aa,stroke:#9a3412,stroke-width:2px,color:#1c1917
    classDef defensive fill:#dcfce7,stroke:#15803d,stroke-width:2px,color:#1c1917
    classDef operating fill:#e0f2fe,stroke:#075985,stroke-width:1px,color:#1c1917
    class Ntruist_bank focal
    class Nlifenet_health_skin_and_wound_allograft_institute operating
    class Nlifenet_health_and_skin_and_wound_allograft_institute operating
    class Nbraemar_manufacturing operating
    class Nsuntrust_bank operating
    class Ncardionet operating
    class Ngeneral_electric_capital_as_agent operating

Patents currently held (5)

Connected entities (3)

Correspondent attorneys (2)

Attorneys / firms recorded with USPTO when this entity received a patent. Recurrence is the signal — many firms do both NPE and operating-company patent work, so a single appearance doesn’t mean much.